Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK

Atherosclerosis - Tập 210 - Trang 114-121 - 2010
Xiao-Mei Bao1, Chun-Fang Wu1, Guo-Ping Lu1
1Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Road II, Shanghai 200025, PR China

Tài liệu tham khảo

Bautista, 2002, Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies, J Clin Epidemiol, 55, 882, 10.1016/S0895-4356(02)00434-1 Weiss, 2002, Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia, Vasc Med, 7, 227, 10.1191/1358863x02vm428ra Vignini, 2004, Modification induced by homocysteine and low-density lipoprotein on human aortic endothelial cells: an in vitro study, J Clin Endocrinol Metab, 89, 4558, 10.1210/jc.2004-0419 Hill, 2003, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk, New Engl J Med, 348, 593, 10.1056/NEJMoa022287 Walter, 2002, Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells, Circulation, 3017, 10.1161/01.CIR.0000018166.84319.55 Zhu, 2006, Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia, Arch Med Res, 37, 484, 10.1016/j.arcmed.2005.09.017 Chen, 2004, Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood, J Mol Cell Cardiol, 36, 233, 10.1016/j.yjmcc.2003.10.005 Tan, 2006, Hyperhomocysteinemia inhibits post-injury reendothelialization in mice, Cardiovasc Res, 69, 253, 10.1016/j.cardiores.2005.08.016 Alam, 2009, Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis, J Cereb Blood Flow Metab, 29, 157, 10.1038/jcbfm.2008.99 Noor, 2007, High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis, Atherosclerosis, 192, 92, 10.1016/j.atherosclerosis.2006.06.023 Zhu, 2006, Homocysteine accelerates senescence and reduces proliferation of endothelial progenitor cells, J Mol Cell Cardiol, 40, 648, 10.1016/j.yjmcc.2006.01.011 Alvarez-Maqueda, 2004, Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration, Atherosclerosis, 172, 229, 10.1016/j.atherosclerosis.2003.11.005 Weiss, 2005, Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function, Curr Drug Metab, 6, 27, 10.2174/1389200052997357 Ungvari, 2003, Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NADPH oxidase, and inducible nitric oxide synthase, Arterioscler Thromb Vasc Biol, 23, 418, 10.1161/01.ATV.0000061735.85377.40 Carluccio, 2007, Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants, Am J Physiol Heart Circ Physiol, 293, H2344, 10.1152/ajpheart.00432.2007 Urbich, 2005, FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells, FASEB J, 19, 974, 10.1096/fj.04-2727fje Wassmann, 2002, Cellular antioxidant effects of atorvastatin in vitro and in vivo, Arterioscler Thromb Vasc Biol, 22, 300, 10.1161/hq0202.104081 Goettsch, 2009, Nox4 overexpression activates reactive oxygen species and p38 MAPK in human endothelial cells, Biochem Biophys Res Commun, 380, 355, 10.1016/j.bbrc.2009.01.107 El-Remessy, 2008, Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation, Mol Vis, 14, 2190 Uruno, 2008, Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase, Hypertens Res, 31, 2085, 10.1291/hypres.31.2085 Vasa, 2001, Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, Circ Res, 89, E1, 10.1161/hh1301.093953 Ten Freyhaus, 2006, Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation, Cardiovasc Res, 71, 331, 10.1016/j.cardiores.2006.01.022 Li, 2006, Increased migration of vascular adventitial fibroblasts from spontaneously hypertensive rats, Hypertens Res, 29, 95, 10.1291/hypres.29.95 Werner, 2007, Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease, Basic Res Cardiol, 102, 565, 10.1007/s00395-007-0680-1 He, 2004, Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase, Arterioscler Thromb Vasc Biol, 24, 2021, 10.1161/01.ATV.0000142810.27849.8f Bid, 2007, NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways, J Biol Chem, 282, 35373, 10.1074/jbc.M702175200 Kuroda, 2005, The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells, Genes Cells, 10, 1139, 10.1111/j.1365-2443.2005.00907.x